Corbus Pharmaceuticals Holdings, Inc. reported a net loss of $78.5M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Corbus Pharmaceuticals Holdings, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CRBP Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
CRBP Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Corbus Pharmaceuticals Holdings, Inc. financials
Frequently Asked Questions
What was Corbus Pharmaceuticals Holdings, Inc.'s net income in fiscal year 2025?
Corbus Pharmaceuticals Holdings, Inc. reported a net loss of $78.5M in fiscal year 2025.
How fast is Corbus Pharmaceuticals Holdings, Inc.'s net income growing?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported a $40.2M net loss in fiscal year 2024 and a $78.5M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
How has Corbus Pharmaceuticals Holdings, Inc.'s net income changed over the years?
Across the 13 fiscal years this page covers, Corbus Pharmaceuticals Holdings, Inc. (CRBP) net income went from -$602K in fiscal year 2013 to -$78.5M in fiscal year 2025.
What was Corbus Pharmaceuticals Holdings, Inc.'s net income in the most recent quarter?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported -$35.0M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported on that line in every period on record.